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Abstract
In this work, we estimate the proportions of transmissions occurring in main vs. casual partnerships, and by the sexual role,
infection stage, and testing and treatment history of the infected partner, for men who have sex with men (MSM) in the US
and Peru. We use dynamic, stochastic models based in exponential random graph models (ERGMs), obtaining inputs from
multiple large-scale MSM surveys. Parallel main partnership and casual sexual networks are simulated. Each man is
characterized by age, race, circumcision status, sexual role behavior, and propensity for unprotected anal intercourse (UAI);
his history is modeled from entry into the adult population, with potential transitions including HIV infection, detection,
treatment, AIDS diagnosis, and death. We implemented two model variants differing in assumptions about acute
infectiousness, and assessed sensitivity to other key inputs. Our two models suggested that only 4–5% (Model 1) or 22–29%
(Model 2) of HIV transmission results from contacts with acute-stage partners; the plurality (80–81% and 49%, respectively)
stem from chronic-stage partners and the remainder (14–16% and 27–35%, respectively) from AIDS-stage partners. Similar
proportions of infections stem from partners whose infection is undiagnosed (24–31%), diagnosed but untreated (36–46%),
and currently being treated (30–36%). Roughly one-third of infections (32–39%) occur within main partnerships. Results by
country were qualitatively similar, despite key behavioral differences; one exception was that transmission from the
receptive to insertive partner appears more important in Peru (34%) than the US (21%). The broad balance in transmission
contexts suggests that education about risk, careful assessment, pre-exposure prophylaxis, more frequent testing, earlier
treatment, and risk-reduction, disclosure, and adherence counseling may all contribute substantially to reducing the HIV
incidence among MSM in the US and Peru.
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Introduction
Three decades on, the HIV epidemic in the United States and
other highly developed nations remains concentrated among men
who have sex with men (MSM), with over half of new infections
occurring in this community [1]. The same is true throughout
Latin America [2]. In the US, HIV incidence is rising among
young MSM, especially Blacks [3]. Incidence trends for Latin
American MSM are less well characterized, although prevalence
remains high in this community throughout the region [4].
Recent advances in pre-exposure prophylaxis [5], testing [6],
antiretroviral treatment-as-prevention [7] and circumcision
[8,9,10] have raised hopes for HIV prevention, including among
MSM. While none alone is likely to stop the epidemic, larger
reductions in incidence may be achieved by prevention packages,
tailored to individual risks and preferences, that combine some or
all of these new interventions with new and existing counseling
approaches that support adherence, more frequent HIV testing,
and continued sexual risk reduction.
Optimizing prevention packages will require a better under-
standing of HIV transmission in these populations. Recent work
has estimated the proportion of new infections among developed-
world MSM that occur within main partnerships [11,12,13,14],
during acute infection [15,16,17,18,19,20,21,22,23,24], and by the
sexual role [13], testing history, and treatment status of the
infected partner [22,25]. These studies use methods ranging from
cross-sectional modeling to phylogenetics, start from varying
assumptions, and typically address only one or two of these
questions. Similar work on MSM transmission dynamics in
developing world settings is lacking.
In this paper we jointly estimate these key epidemiological
measures among urban MSM populations in the US and Peru.
Both countries have epidemics concentrated among MSM [2],
and, despite population differences in socioeconomic status,
PLOS ONE | www.plosone.org 1 November 2012 | Volume 7 | Issue 11 | e50522health care access, and sexual behaviors, HIV prevalence
among urban MSM in each country appears to be roughly
similar [26,27]. This work represents the baseline modeling
results for the Prevention Umbrella for MSM in the Americas
(PUMA) project, which aims to identify more effective ways of
combining and targeting HIV interventions for MSM through-
out the Western Hemisphere.
Methods
Overview
We use dynamic, stochastic, network models, one for the US
and one for Peru, parameterized using multiple large-scale
behavioral and demographic surveys of MSM, including NHBS
[26,28], Peru’s Sentinel Surveillance [29], HPTN-036 [30], and
the baseline surveys of HPTN-039 [31] and Explore [32,33]. All
are focused on large urban centers, and most have some definition
of high risk for their inclusion criteria, so our models reflect these
populations. The models simulate parallel networks for main
partnerships and casual sexual contacts, both implemented using
exponential random graph models (ERGMs) in the R package
suite statnet [34], with some extensions. The main/casual
distinction parallels that from source studies, which generally
define a main partnership in terms of emotional commitment.
Additional model components are also programmed in R. Model
features and inputs were determined in consultation with a team of
HIV researchers and community advisory board members. Unlike
compartmental models, network models are not easily presented
through flow diagrams; instead, we provide an analogous
summary of model structure in Table 1. Additional detail,
including parameter values, is provided in the Supporting
Information.
Overall Population
Our models work by simulating the day-by-day history of a
population of MSM, beginning with 10,000 men. Individuals
vary according to fixed characteristics including race, circum-
cision status, sexual role, and propensity for UAI in casual
sexual contact; sexual role is modeled as varying continuously
from exclusively insertive to exclusively receptive. Men enter the
population at age 18 and are followed until age 65 or death,
whichever comes first. The assumed entry rate results in slow
population growth in the presence of a stable HIV epidemic.
Non-AIDS-related mortality rates are based on published life
tables; in men who never receive treatment, disease progression
to AIDS occurs 10 years after HIV infection, and death from
AIDS occurs 2 years later; progression is slower and survival
greater for men on ART, and varies by magnitude of adherence
and viral suppression (see below). Models were begun with 19%
prevalence [26], run through a burn-in period to eliminate the
transient effects of seeding the infection arbitrarily, and then
compared to observed HIV incidence and prevalence in these
populations. We discuss the burn-in in more depth in the online
technical supplement, and its relationship to our outcomes.
Each scenario is modeled 10 times, for 25 years.
Main Partnerships
Day by day, we simulate the formation and subsequent
dissolution of main partnerships, the occurrence of unprotected
anal intercourse (UAI) within them, and HIV transmission if one
partner is infected. Under the ERGM, main partnership
formation reflects each potential partner’s sexual role, race, age,
and current partnership status. Partnerships between men with
incompatible sexual roles (two strictly insertive or receptive men)
are disallowed. After formation, the daily risk of main partnership
dissolution is assumed constant, so partnership duration follows a
geometric distribution. If either partner is infected, daily UAI
probability varies by whether the infection has been diagnosed and
disclosed. UAI rates are further reduced once either man develops
clinical AIDS. Sexual role may vary across UAI episodes,
according to the sexual roles of both partners.
Table 1. Model features.
Agent attributes. Each man (agent) in the
model possesses the following attributes:
Network models. The probabilities governing
relations between pairs:
Transitions. The following changes can
happen to men:
Age Main partnerships evolve as a function of: Entrance into population
Race (US only) Age of men Aging
Circumcision status Race of men (US only) Infection
Sexual role preference # of partnerships men are already in Change in viral load
Propensity for casual UAI UAI occurs w/in main partnerships as function of: Progression through disease stages
Infection status Disclosure and diagnosis status of men Testing
Diagnosis status Disease stage of men Treatment initiation
Viral load (for HIV+ men) Men’s sexual roles Death from AIDS
Stage of infection (for HIV+ men) Casual UAI occurs as a function of: Death from other causes
Treatment status (for HIV+ men) Age of men Sexual retirement
Treatment adherence and suppression Race of men (US only)
Testing propensity Men’s propensity for casual UAI
Duration since sexual debut Men’s disclosure and diagnosis status
Duration since last negative test Disease stage of men
Duration since infection Men’s sexual roles
Duration since positive diagnosis
doi:10.1371/journal.pone.0050522.t001
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In parallel, we simulate UAI in casual contacts and resulting
HIV transmission. Specific contacts reflect the sexual role, age,
race, and HIV serostatus of each partner, as well as his propensity
for UAI in casual contacts. As with main partnerships, contacts
between men with incompatible sexual roles are disallowed, and
only UAI risk is considered.
HIV Transmission
When a UAI contact occurs between serodiscordant partners,
per-contact HIV transmission risk is made to depend on the role of
the uninfected partner, and if he is insertive, whether he is
circumcised. In the US model, circumcision prevalence varies by
race, and declines over time, while for Peru prevalence is constant.
Per-contact transmission risk is also made to depend on the time
since infection of the infected partner as well as his treatment
status, mediated by viral load, as described below.
Transmission probabilities are not as well documented for
MSM as for heterosexuals; the one serodiscordant couple study
of transmission by time since infection focused on heterosexual
transmission [35], as have all three studies of circumcision
[8,9,10]. Our initial approach (Model 1) focused exclusively on
viral load differences as the source of acute hyperinfectiousness.
However, new research published during the course of this
project suggests that acute infection viral strains may be more
infectious even after accounting for viral load [36,37]. We thus
implemented a second variant (Model 2) that considered these
additional potential sources. We explore both models for both
countries.
In Model 1, we based infection rates on viral load and per-
contact risk in the absence of treatment, modeled with parametric
curves [38,39,40]. These estimates did not take into account stage
of infection independent of viral load. Viral load rises and falls
over 40 days post-infection; chronic infection lasts for a subsequent
ten years in the absence of treatment, followed by two years of
rising viral load during late-stage infection; then death. Per-contact
risk ratios by sexual role and circumcision status of an uninfected
insertive partner were determined by estimates for anal [41] and
vaginal sex [8], respectively.
In Model 2, we used infection stage and per-contact risk in the
absence of treatment, without explicit consideration of viral load.
The acute stage is assumed to last two months, with infectiousness
rising in the first month and falling in the second; subsequent
changes in per-contact risk follow the patterns from Model 1,
except for the slope of infectiousness during late-stage. We derived
risk ratios for the average risk in each stage from estimates of relative
per-contact risk by stage for UAI among heterosexuals [35];
infectiousness slopes during acute and late stages were fit to yield
these average stage-specific relative risks. Risk ratios by role and
circumcision status were carried over from Model 1. Given
uncertainty in absolute risk in this framework, per-contact risks
were calibrated to yield HIV prevalence for the stable epidemic
equal to Model 1.
The infectiousness curve implied by each model in the absence
of treatment is summarized by Figure 1a (acute stage) and
Figure 1b (AIDS stage).
Testing, Treatment, and Infectiousness
We simulate HIV testing, and, after an infection has been
diagnosed, when treatment begins. In both models, infectiousness
on treatment is mediated by viral load.
Men become eligible for treatment initiation when their
expected CD4+ count, modeled as a function of time since
infection [42], drops below country-specific thresholds, which
are also race-specific for the US. Thresholds are determined by
observed CD4+ counts at initiation, and are driven by a variety
of factors such as testing frequencies and access to health care.
Explicitly modeling a wide range of patterns of treatment
initiation, levels of adherence, cessation, and potential re-
initiation was beyond the scope of the model, since the data
needed to do so were limited (particularly in terms of survival
for men with arbitrarily complex treatment histories). Instead,
we reduce this complexity down to three representative
trajectories: a proportion of randomly selected men in each
country never initiate treatment; among those who do, some
achieve partial and some full viral suppression, depending on
adherence. Parameters are set to achieve the prevalence of three
states in cross-sectional data: the proportion of men who are not
on treatment; on treatment and partially suppressed; and on
treatment and fully suppressed. Rates of progression to AIDS
and death, as well as infectiousness, vary across these groups. In
particular, per-contact risks are motivated by published
estimates of mean viral load [43] for each group, in
combination with the relationship of viral load to infectiousness
from Model 1. With disease progression, viral load and thus
infectiousness increase again until death [40]. Results suggest a
93% reduction for full suppression as compared to untreated
men, qualitatively similar to the 96% recently reported [7].
Sensitivity Analyses
Models 1 and 2 vary in their treatment of infectiousness early in
infection. To obtain estimates of uncertainty due to key model
inputs, we conducted sensitivity analyses varying three particularly
uncertain and/or influential inputs: duration of main partnerships;
relative frequency of UAI in main partnerships and casual
contacts; and HIV testing frequency.
Results
Prevalence and Incidence
In Model 1, prevalence at steady state across repeated
simulations averages 28% for the US and 29% for Peru, and
mean annual incidence is 1.8% and 1.9%, respectively. The US
prevalence estimate is slightly higher than the 25% found in most
cities in the first MSM round of NHBS [44], an expected pattern
given that most source datasets excluded MSM with no HIV risk.
For Peru, there is less clear documentation of recent incidence and
prevalence. Reports of HIV prevalence for Lima in the early 2000s
were just above 20%, and increasing by 6% year over year [27]; if
that trend has continued, prevalence should be ,30% in recent
years. Other Peruvian cities have lower prevalence, but our model
mainly reflects inputs for Lima, home to 73% of the country’s
diagnoses [45]; source data here also exclude men with no HIV
risk.
Infection Stage, Diagnosis and Treatment
Model 1– in which infectiousness is mediated by viral load–
predicts only a small role for acute infection (5% in the US and
4% in Peru) and a dominant role for chronic infection (81%
and 80%, respectively; Figure 2). In contrast, Model 2–which
uses a stage-based model for viral load in the absence of
treatment– estimates a more equal balance, but still a plurality
for chronic (29%, 44%, 27% for acute/chronic/late in the US;
22%, 43%, 35% in Peru). The distribution of transmissions by
detection and treatment also varies by model; nevertheless, in all
cases transmissions are roughly balanced across the undiag-
nosed, untreated, and treated groups.
US and Peruvian HIV Epidemics in MSM
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Model 1 consistently estimates that UAI within main partner-
ships is the source of ,39% of infections in the US and ,35% in
Peru, despite constituting 52% and 48% of UAI acts, respectively.
Results for Model 2 are slightly lower.
Sexual Role
Transmissions by sexual role showed the greatest international
difference. Model 1 estimated that in the US, only 21% of
transmission was from the receptive to the insertive partner,
compared to 34% for Peru; Model 2 is qualitatively similar. This
can be partly attributed to the lower prevalence of circumcision–
assumed to lower UIAI risk by 60%–in Peru, in combination with
greater role exclusivity; in the latter context, transmission to more-
or-less exclusively insertive men must play a bigger role in
sustaining chains of infection.
Variation in Outcomes
Our metrics on transmission types varied little across runs
within the same scenario, never ranging over more than 2
percentage points. This is due to both our large population size
and to the long time period (25 years) over which we modeled
them. Variation in metrics was of course higher over the short
term, and this short-term variation can be of interest. Figure 3
shows the distribution for each outcome metric when measured for
each of the 25 years separately, for the US Model 1. Analogous
plots for the other country/model combinations are in the online
technical supplement. Each shows a qualitatively similar pattern:
for our population, these metrics see most of their variation lie with
a roughly ten percentage-point range. It is important to remember
that the magnitude of this range is still a function of our population
size (,10,000, with roughly 150 new infections per year). Smaller
populations would see more variation; those that are larger, with
sexual partnerships forming throughout the population, would see
less.
Figure 1. Per-act infectivity by time since infection, during acute stage (Figure 1a) and AIDS state (Figure 1b). For more information on
the derivation, see the online technical supplement.
doi:10.1371/journal.pone.0050522.g001
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Analyses were conducted to assess sensitivity to three particu-
larly uncertain model inputs. We present these for Model 1 in
Figure 4. Average main partnership duration is hard to estimate,
with a strongly right-skewed distribution, censoring, and recall
bias. We varied this input, holding the prevalence of main
partnerships constant (Figure 4a). Results were only mildly
sensitive to partnership length.
Given the divergence between our estimates of the proportion of
transmissions occurring in main partnerships and other published
estimates, we explored the impact of different assumptions about
the relative frequency of UAI in main partnerships versus casual
contacts (Figure 4b). Specifically, we increased the frequency in
main partnerships by 10–40%, simultaneously reducing its
frequency in casual contacts by the same percentage. As expected,
the proportion of transmissions occurring in main partnerships
correlates positively with the relative frequency of UAI in these
partnerships. However, it remains much lower than the proportion
of all UAI contacts occurring in these partnerships, reflecting the
fact that transmission can only occur once in any partnership.
Moreover, the estimated proportion of main-partner transmissions
never exceeds 50%, even with very large increases in the relative
UAI frequency; this reflects the need for casual contacts to sustain
chains of infection.
Data on the proportion of men reporting testing in the last
year, used in our models, generally suggest higher testing
frequency than estimates based on self-reported infection status
among men testing positive [26,44,46]. Even with testing at half
our estimated frequency (Figure 4c), men with diagnosed
infection generate a majority of transmissions. At lower testing
rates, this proportion necessarily drops, but reaches a lower
bound; in addition, HIV prevalence in these models increases to
less realistic levels.
Discussion
Our models are the first to comprehensively and consistently
address several questions about HIV transmission, including the
proportions of transmissions occurring during acute as well as
undiagnosed, untreated, and partially suppressed infection, within
main partnerships, and to insertive partners in anal intercourse.
Our results help clarify these questions for MSM in sites on two
continents, with implications for prioritizing prevention efforts and
designing combination prevention interventions, including the
PUMA package currently in development.
Although variation in infectiousness soon after HIV acquisition
is not well understood for MSM, leading us to develop two
variants of our models, nonetheless both suggested that a
considerably smaller percentage of transmissions occur during
acute infection than some recent estimates based on phylogenetic
clusters [15,18,24,47]. Newer work has critiqued the statistical
methods used in some of those papers, and developed their own
estimates based on similar data types [16,17]; these, as well as
other modeling estimates [19,20,23], lie closer to our more
conservative estimate of 4–5%. Our less conservative estimates of
22% in Peru and 29% in the US are more similar to one modeling
estimate for Australia [22]. Recent work [36,37] suggesting that
additional factors beyond just viral load induce high transmissi-
bility during acute infection would argue for the less conservative
estimates, although further clarification on acute infectiousness for
MSM is urgently needed. The lower estimate for Peru may reflect
lower circumcision prevalence, later treatment initiation, and less
suppression due to lower adherence among the treated, all of
which make post-acute transmission more likely. However, all of
our estimates suggest that strategies to increase testing for men
regardless of stage of infection may be more fruitful than some
phylogenetic work seems to imply, and that efforts focused
narrowly on the more difficult task of identifying acute-stage
men are not as crucial.
Figure 2. Distribution of transmission events by key variables. Bars represent the means across ten stochastic simulations over 25 years. The
variance of these estimates across runs was less than 2 percentage points for all measures, so only means are shown. For year-on-year variation, see
the Figure 3 and the online technical supplement.
doi:10.1371/journal.pone.0050522.g002
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transmissions stem from undiagnosed, diagnosed but untreated,
and inadequately-treated men in both countries. This argues that
earlier treatment initiation and strategies to maintain retention in
care and adherence to treatment must be linked to testing, and all
should be included in comprehensive prevention packages. These
data are consistent with recent findings from two different studies
that ,30% of HIV-infected Americans are virologically sup-
pressed [48,49].
None of the six CDC ‘‘evidence-based’’ interventions for MSM
address transmission within stable partnerships, which comprise
35–39% of all infections in our results, comparable to other recent
Figure 3. Range of variation from year to year for outcome metrics. Each boxplot covers the values for a given outcome metric measured for
each of the 25 years in a single run. We show US Model 1 here as demonstration; comparable plots for the other three country/model combinations
are in the online technical supplement.
doi:10.1371/journal.pone.0050522.g003
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world estimates (86% [14] and 68% [13]) were considerably
higher, the first of these defined stable partnerships more broadly
and focused on young men, who switched steady partners
frequently; the second is based on a simpler model that does not
explicitly account for dynamic network structure, and uses a
different estimate of relative UAI frequency in stable partnerships
vs. casual contacts (Sullivan, personal communication). Despite the
variability of these estimates, they are consistent in suggesting that
substantial HIV transmission occurs in main partnerships in both
the US and Peru, and thus support development and evaluation of
behavioral interventions for MSM couples. Definitions for main
partnerships were similar in source studies (generally reflecting
emotional commitment), but the nature of such partnerships may
differ considerably by country, and needs to be better understood.
Less is known about the proportion of HIV transmission from
receptive to insertive anal sex partners. We estimated that 21% of
transmissions are in this direction, similar to an earlier estimate of
28% [13], for US MSM; the slight difference may reflect the fact
that our model explicitly requires the numbers of receptive and
insertive acts to be equal. We found no estimates of transmissions
by role for Peru. Our estimate of 33% is higher than for the US,
despite the apparent belief among some MSM in Lima that the
insertive partner is at very low risk. This misconception leads to
another: specifically, that exclusively insertive men are highly
unlikely to be HIV infected and therefore pose no risk to their
HIV negative receptive partners. Our findings suggest that
messages addressing these misconceptions should figure promi-
nently in risk reduction counseling for MSM with any sexual role,
especially in the context of greater role exclusivity. Another
implication is that promotion of circumcision might be a useful
intervention among nearly or exclusively insertive MSM, at least
in South America, where circumcision is relatively uncommon and
seems protective among highly-insertive men [50]. However, cost
and limited uptake could limit the effectiveness of this approach,
especially since exclusively insertive men are disproportionately
heterosexually-identified, and thus likely to not be open about
their sexual activities with other men [51]. Counseling messages
should emphasize that although receptive anal sex carries the
highest risk, a substantial proportion of infections is also caused by
insertive anal sex.
As with all models, our approach has numerous limitations.
Some parameters are based on one data source, especially for
Peru, and inputs are generally subject to bias and sampling error.
Stage-specific estimates of per-act transmission were only available
for heterosexuals; similar MSM measures are urgently needed.
Although our model was more detailed than most, modeling
always requires simplification, in part because data for more
complicated models are commonly lacking. For example, we did
not model temporal variability in treatment effectiveness, possibly
leading to some underestimation of risk in main partnerships,
where undetected treatment failure would be risky if partners
relied on full suppression rather than condoms. Also, while our
study represents an advance on earlier models in explicitly
modeling main and casual partnerships separately, we did not
explicitly model partnerships involving repeated contacts with
partners not perceived as ‘‘main,’’ but rather treated these as
separate casual contacts. This could understate the importance of
long-term relational concurrency, and provides no explicit
guidance for counseling MSM about these relationships. It could
also affect overall incidence in our model, and underestimate the
proportion of infections in main partnerships by allowing someone
to transmit to multiple casual partners in the model who are in
reality the same person. In addition, we did not model contacts
with females, a population at potentially substantial secondary risk
in each setting. However, given the relatively low HIV prevalence
Figure 4. Sensitivity analyses. a) Changes in main partnership duration relative to base model (100%). b) Changes in main and casual UAI relative
to base model (100%). c) Changes in testing frequency relative to base model (100%).
doi:10.1371/journal.pone.0050522.g004
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transmissions are unlikely to play any substantive risk for MSM in
the Americas, as opposed to settings of generalized epidemics, e.g.
southern Africa. We did not explicitly model male sex work or
transgender identity, two aspects of MSM life of particular
importance in Peru; however, men involved in either were
included in source studies and thus contribute to model
parameters. Finally, our data were limited to two countries–the
US and Peru. Generalizing either model to other countries in the
Americas should only be done with caution, as there remains
much work to do in determining whether key inputs are similar for
MSM in other settings.
In a pre-planned extension of this work, we will model the
potential effects of various interventions in MSM, including pre-
exposure prophylaxis (PrEP), which could dramatically change the
prevention landscape for MSM. We will also assess the maximal
predicted impact of voluntary medical male circumcision, which is
likely to be incorporated into many prevention packages for
heterosexuals in Africa, but whose impact in MSM, even in
populations with substantial role segregation, is less clear. Using
data from these models, we are building a combination prevention
package for MSM in North and South America. The PUMA
package is likely to include PrEP (with strategies to improve
medication adherence), home HIV testing with online and
telephone support and linkage to care, couples-based interven-
tions, and more explicit risk reduction counseling information. We
hope that through the combination of these prevention strategies
for HIV uninfected persons and improved treatment coverage and
adherence in HIV infected persons, we can halt the growing HIV
epidemic in MSM throughout the Americas.
Supporting Information
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